PHASE II TRIAL OF SECOND-LINE ERLOTINIB AND DIGOXIN FOR NONSMALL CELL LUNG CANCER (NSCLC)

Fadi Kayali, Muhamad A Janjua, Damian A Laber, Donald Miller, Goetz H KloeckerUniversity of Louisville, James Graham Funko Rewind Brown Cancer Center, Louisville, KY, USABackground: In vitro digoxin sensitizes cancer cells to the induction of apoptosis by chemotherapy.Inhibition of the Na/K-ATPase enzyme by ouabain disturbs the intracellular ion co

The low penetration in Brazil of critical theories regarding humanitarian interventionism reflects itself in the scarcity of academic works able to put into question the United Nations Mission for the Stabilization of Haiti (Minustah).This article aims at filling part of those gaps by presenting a range of Amino Acids theoretical tools available el